Skip to main content
Category

News Archive

landos-biopharma-logo

Mechanistic and Human Translational Results for BT-11 in Models of IBD – Landos Biopharma

By News Archive

landos-biopharma-logo

Landos Biopharma, Inc., an emerging biopharmaceutical company focused on developing improved treatments for autoimmune diseases, announced the publication of findings on the mechanisms of action for its top lead candidate, BT-11, in Inflammatory Bowel Diseases, the Official Journal of the Crohn’s & Colitis Foundation. The study concludes that through the activation of the Lanthionine Synthetase C-Like 2 (LANCL2) pathway, BT-11 induces changes in the interface of inflammation and metabolism within immune cells in the gut that are critical to provide lasting therapeutic efficacy against inflammatory bowel disease (IBD). These changes in metabolism enhance regulatory CD4+ T helper cell responses and promote lasting therapeutic actions locally within the gut. The mechanistic findings demonstrate the translatability of the therapeutic efficacy of BT-11 to the clinic.

Read More
biobuzz networking event 2017 121

BioBuzz with UMBC Shady Grove

By News Archive

biobuzz-networking-event-2017-121

When: Wednesday, May 16, 2018 from 5:00 PM to 7:00 PM EDT

Where: UMBC Shady Grove, 9630 Gudelsky Drive ,Rockville, MD 20850

Join BioBuzz and sponsor UMBC Shady Grove in Rockville on May 16th for our next great networking event. UMBC at The Universities at Shady Grove (USG) has a 17+ year history of providing high caliber and industry desired academic programs in Rockville, MD. This Fall, UMBC is launching its first Bachelors of Science degree at USG in Translational Life Science Technology. This degree, designed in partnership with Montgomery College, combines the theory of a traditional life science degree with real-world applications used by scientists in academic and industry research. 

Read More
va-beach-bio-logo

VA BEACH BIO INNOVATION CHALLENGE Letter of Intent Form

By News Archive

va-beach-bio-logo

This is the Letter of Intent Form (LOI) for Phase 0 of the VA BEACH BIO INNOVATION Startup Challenge. The Team Leader of each team should fill out and submit one form for this challenge. The last date to submit an LOI is May 31st.

Page 1: Basic information and Confidentiality Page 2: Additional Team information (can be completed during Phase 1)

Anyone can Enter!

No minimum team size – you can enter individually Your Background: Anyone with an entrepreneurial spirit! No Geography Restrictions: This challenge welcomes international participants

Read More
Alex-Azar-hhs-linkedin-image

HHS Secretary Alex Azar Gives Industry Leaders a Map of the New Healthcare – Healthcare Blogs

By News Archive

Alex-Azar-hhs-linkedin-image

It was quite fascinating to cover the speech that Health and Human Services Secretary Alex Azar gave this week in Washington, D.C. In a keynote address on Wednesday morning at the Marriott Wardman Park Hotel, Secretary Azar laid out his agency’s overall policy strategy, for attendees at the World Health Care Congress, which annually gathers together leaders from all the major sectors of the U.S. healthcare industry, from hospitals to physician groups to post-acute and behavioral healthcare, to health plans/health insurers, employer-purchasers, pharmaceutical leaders, and healthcare IT leaders. It’s an ideal venue for senior federal healthcare officials to make announcements—and they usually do show up every year, and sometimes, make news.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.